Back to all articles
Health

Weight-Loss Injections: What WHO's First Guideline on GLP-1 Medicines Means for You

08 July 2026 · 2 min read · Reviewed by our medical team

Medicines such as semaglutide, tirzepatide and liraglutide, often called "GLP-1 medicines", have changed how doctors treat obesity. In December 2025 the World Health Organization published its first global guideline on their use. Here is what it says, in plain language.

How these medicines work

GLP-1 medicines imitate natural gut hormones that tell the brain you are full. They slow down stomach emptying and reduce appetite, so people eat less. In large clinical trials, combined with diet and exercise, adults lost on average about 15% of their body weight with semaglutide and up to about 20% with the highest dose of tirzepatide over roughly a year and a half. In people with heart disease and excess weight, semaglutide also lowered the risk of heart attack and stroke.

What WHO recommends

  • GLP-1 medicines can be used for the long-term treatment of obesity (body mass index 30 or more) in adults, but not in pregnancy.
  • They should be combined with support for healthy eating and physical activity.
  • The recommendations are "conditional": more evidence is still needed on long-term safety, on what happens after stopping, and on cost and fair access.

What to know before you start

  • Side effects: nausea, vomiting, diarrhoea or constipation are common, especially when the dose goes up. Rare but serious problems include inflammation of the pancreas and gallbladder disease.
  • Weight tends to come back after stopping. Like blood pressure medicines, these are long-term treatments.
  • Protect your muscles: eat enough protein and add strength exercises, so that you lose fat rather than muscle.
  • Not for everyone: they are not used during pregnancy or breastfeeding, or in people with a personal or family history of medullary thyroid cancer or MEN2 syndrome.
  • Beware of fakes. WHO has warned about falsified semaglutide sold online and through unofficial channels. Use only medicines prescribed by a doctor and bought in a licensed pharmacy.

Is it right for you?

These medicines are a tool, not a shortcut. A doctor should check your weight, blood pressure, blood sugar, cholesterol and other risks, discuss whether a GLP-1 medicine suits you, and plan regular follow-up. At FMRC, our family doctors and endocrinologist can help you build a realistic plan. Call 0 422 277 303 or book a visit online.

Sources: WHO guideline on the use of GLP-1 medicines in treating obesity (1 December 2025); WHO medical product alert on falsified semaglutide; STEP 1, SURMOUNT-1 and SELECT clinical trials.

Reviewed by our medical team

All FMRC articles are reviewed for accuracy by board-certified clinicians at the Family Medical Regional Centre, Batumi.

Have a health concern? Talk to a specialist.

Most appointments at FMRC are available within 48 hours.

Book Appointment

Your health is in reliable hands

Book an Appointment